Pharmaceutical Research and Manufacturers of America spent more than $12.2 million on lobbying in the first quarter of 2026, its second-highest quarterly total on record after the first quarter of 2025, according to disclosures filed Tuesday.
The nation’s top drug industry trade group ranks third in overall lobbying spending this quarter and spent nearly $38 million last year.
President Donald Trump has been heavily pushing Congress to codify a policy that would link US drug prices to lower prices in other countries, something that PhRMA strongly opposes. PhRMA is also searching for a new president and CEO to replace